British American Tobacco Industries p.l.c. (BTI) vs Trulieve Cannabis Subordinate Voting Shares (TRLV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Trulieve Cannabis Subordinate Voting Shares (TRLV) has outperformed British American Tobacco Industries p.l.c. (BTI) over the past year, gaining 18.0% versus a gain of 7.4%. Over five years, BTI leads with a +49.3% price change compared with -60.5% for TRLV. British American Tobacco Industries p.l.c. is the larger company by market cap ($119.23 billion vs $2.00 billion), about 59.7 times the size.
On valuation, British American Tobacco Industries p.l.c. trades at a lower forward P/E (10.6x vs 18.6x for Trulieve Cannabis Subordinate Voting Shares). British American Tobacco Industries p.l.c. pays a dividend yielding 4.42%, while Trulieve Cannabis Subordinate Voting Shares does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BTI | TRLV |
|---|---|---|
| Share price | $55.43 | $10.37 |
| Market cap | $119.23B | $2.00B |
| 1-day change | +2.84% | -3.80% |
| YTD return | -2.10% | +19.33% |
| 1-year return | +7.42% | +17.97% |
| 5-year return | +49.31% | -60.45% |
| P/E ratio (TTM) | 14.21 | — |
| Forward P/E | 10.58 | 18.63 |
| EPS (TTM) | $3.90 | $-2.43 |
| Dividend yield | 4.42% | 0.00% |
| Annual dividend | $2.45 | $0.00 |
| 52-week high | $67.30 | $13.28 |
| 52-week low | $49.88 | $4.62 |
| Distance from 52-week high | -17.64% | -21.91% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +27.06% | +75.31% |
| Average volume | 4.58M | 1.61M |
| Shares outstanding | 2.15B | 170.16M |
| Employees | 47,797 | 5,000 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- British American Tobacco Industries p.l.c. is about 59.7 times larger than Trulieve Cannabis Subordinate Voting Shares by market value ($119.23B vs $2.00B).
- TRLV has outperformed BTI by 10.6 percentage points over the past year.
- British American Tobacco Industries p.l.c. offers a meaningfully higher dividend yield (4.42% vs 0.00%).
About British American Tobacco Industries p.l.c.
BTI stock →British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the United States, Europe, Latin America, Canada, the Asia-Pacific, the Middle East, Central Asia, Caucasus, and Africa.
Health Care · Medicinal Chemicals and Botanical Products · 47,797 employees
About Trulieve Cannabis Subordinate Voting Shares
TRLV stock →Trulieve Cannabis Corp. operates as a cannabis retailer in the United States.
Health Care · Medicinal Chemicals and Botanical Products · 5,000 employees
BTI vs TRLV FAQ
Which is bigger, British American Tobacco Industries p.l.c. or Trulieve Cannabis Subordinate Voting Shares?
British American Tobacco Industries p.l.c. (BTI) is larger, with a market capitalization of $119.23B compared with $2.00B for Trulieve Cannabis Subordinate Voting Shares (TRLV).
Which stock has performed better over the past year, BTI or TRLV?
TRLV returned +17.97% over the past 12 months, compared with +7.42% for BTI (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, British American Tobacco Industries p.l.c. or Trulieve Cannabis Subordinate Voting Shares?
British American Tobacco Industries p.l.c. pays a dividend yielding 4.42%, while Trulieve Cannabis Subordinate Voting Shares does not currently pay a regular dividend.
Are British American Tobacco Industries p.l.c. and Trulieve Cannabis Subordinate Voting Shares in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.